EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.24.61 | Acute Coronary Syndrome |
28747015 |
Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
1
3 |
| 3.4.24.61 | Acute Coronary Syndrome |
29885690 |
Reply: Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
2
2
0 |
| 3.4.24.61 | Acute Coronary Syndrome |
29885698 |
Nardilysin: A potential biomarker for the early diagnosis of acute coronary syndrome. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
4
4
0 |
| 3.4.24.61 | Acute Coronary Syndrome |
30213604 |
Nardilysin: A potential biomarker for the early diagnosis of acute coronary syndrome. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
4
4
0 |
| 3.4.24.61 | Acute Coronary Syndrome |
30661548 |
Response to Letter of Stephenson et al.: Nardilysin: A potential biomarker for the early diagnosis of acute coronary syndrome. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
2
3
0 |
| 3.4.24.61 | Adenocarcinoma |
29798841 |
Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. |
ongoing research
therapeutic application
unassigned |
4
2
0 |
| 3.4.24.61 | Alzheimer Disease |
19234765 |
Reduced neuronal co-localisation of nardilysin and the putative alpha-secretases ADAM10 and ADAM17 in Alzheimer's disease and Down syndrome brains. |
causal interaction
ongoing research
unassigned |
4
1
0 |
| 3.4.24.61 | Alzheimer Disease |
21801775 |
Retinoic acid-induced upregulation of the metalloendopeptidase nardilysin is accelerated by co-expression of the brain-specific protein p42(IP4) (centaurin ?1; ADAP1) in neuroblastoma cells. |
causal interaction
unassigned |
2
0 |
| 3.4.24.61 | Alzheimer Disease |
23604405 |
Nardilysin in human brain diseases: both friend and foe. |
diagnostic usage
ongoing research
unassigned |
2
2
0 |
| 3.4.24.61 | Alzheimer Disease |
23954170 |
Nardilysin prevents amyloid plaque formation by enhancing ?-secretase activity in an Alzheimer's disease mouse model. |
causal interaction
therapeutic application
unassigned |
1
1
0 |
